Marketing Regulation

We provide legal advice to domestic and overseas pharmaceutical companies, medical device manufacturers, bio-venture companies, research insutitute such as universities and contract research organizations (CROs) and other various clients. We have extensive experience advising on licenses, filing and other requirements for the Marketing Authorization Holder (MAH) and the sellers of drugs and medical devices, and drafting and reviewing documents for such bisinesses.

Contact us

Lawyers in charge of Marketing Regulation

PublicationsArchives

2024.01.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 21: Revision to the Administrative Regulation on Wholesale, Retail, etc., of Pharmaceutical Products (Establishment of the Regulation on Supervision and Administration of Business Management and Q
2023.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 20: Notice on Enhancing the Supervision and Administration of Contract Manufacture of Drug Marketing Authorization Holders (No. 132 of 2023)
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.04
China's Life Sciences and Healthcare-No.2 －The Good Vigilance Practice rule in China
2022.05.26
Legal Affairs for Chinese Life Sciences and Healthcare (Part 10) - Toward the Enforcement of the New Cosmetics GMP
2022.03.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 8) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 6) - Trial Program for Cross-border E-commerce Retail Import of Drugs in Henan
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) - Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) -Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)

MORE

SeminarsArchives

2024.10.25
【Online Seminar】 Series of Seminars on M&A in Various Business Fields (4): Pharmacies
2024.08.21
【Online Seminar】 Series of Seminars on M&A in Various Business Fields (2): Medical Devices
2022.10.04
【Onilne Seminar】Life Science Practice Seminar No.8: Legal Practices for Settlement of Pharmaceutical Patent Disputes
2022.09.09
【Online seminar】Catch up on the Latest Practices in 30 Minutes! Concept and Practical Points to Note Regarding Corporate Governance Relating to Tax Affairs; Key Points of the Act on Promotion of Economic Security and Practical Actions Therefor; and Produc
2021.07.09
【Onilne Seminar】Life Science Practice Seminar No.2: Legal Practice for Collection of Pharmaceutical Products, etc.
2021.04.16
【Onilne Seminar】Life Science Practice Seminar No.1: System Operation and Trends Regarding Regenerative Medicine Products as Observed in Recent PMDA Consultation/Approval Cases

MORE

ページTOPへ